BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/22/2021 10:39:22 AM | Browse: 300 | Download: 673
 |
Received |
|
2021-02-02 02:57 |
|
Peer-Review Started |
|
2021-02-02 03:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-08 06:37 |
|
Revised |
|
2021-03-19 17:43 |
|
Second Decision |
|
2021-04-25 12:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-25 13:20 |
|
Articles in Press |
|
2021-04-25 13:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-14 02:20 |
|
Publish the Manuscript Online |
|
2021-05-22 10:39 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Minireviews |
| Article Title |
Hepatic Langerhans cell histiocytosis: A review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhiyan Fu, Hua Li, Mustafa Erdem Arslan, Peter F Ells and Hwajeong Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hwajeong Lee, MD, Associate Professor, Department of Pathology and Laboratory Medicine, Albany Medical Center, 47 New Scotland Ave., MC81, Albany, NY 12208, United States. leeh5@amc.edu |
| Key Words |
Langerhans cell; Liver; Cholangitis; CD1a |
| Core Tip |
Hepatic Langerhans cell histiocytosis (LCH) is characterized by proliferation and accumulation of Langerhans cells in the liver, causing liver dysfunction or forming a mass lesion. There are diverse injury patterns on liver biopsy, including lobular Langerhans cell infiltrate with mixed inflammatory background, primary biliary cholangitis-like pattern, sclerosing cholangitis-like pattern, and even cirrhosis at later stage. The overall prognosis of hepatic LCH is poor. New molecular markers involved in pathogenesis of LCH are being explored with a potential for targeted therapy. |
| Publish Date |
2021-05-22 10:39 |
| Citation |
Fu Z, Li H, Arslan ME, Ells PF, Lee H. Hepatic Langerhans cell histiocytosis: A review. World J Clin Oncol 2021; 12(5): 335-341 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i5/335.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i5.335 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
